Canaural Compositum Suspension for Treatment of Otitis Externa and Dermatosis

국가: 뉴질랜드

언어: 영어

출처: Ministry for Primary Industries

지금 구매하세요

Download 환자 정보 전단 (PIL)
16-05-2019
Download 제품 특성 요약 (SPC)
01-03-2024
Download 공공 평가 보고서 (PAR)
16-05-2019

유효 성분:

diethanolamine fusidate; prednisolone; nystatin; framycetin sulphate

제공처:

Dechra Veterinary Products NZ Limited

INN (International Name):

framycetin sulphate, prednisolone, nystatin, fucidin

구성:

diethanolamine fusidate 5 g/kg; prednisolone 2.5 g/kg; nystatin 100 thou iu/mg; framycetin sulphate 5 g/kg

치료 영역:

Antimicrobial

승인 상태:

ACVM Registered

승인 날짜:

1975-08-01

환자 정보 전단

                                20181120 A2777 15ml Bottle & Carton Label
20181120 A2777 25ml Bottle & Carton Label
20181120 A2777 Common Leaflet
20181120 A2777 Common Leaflet
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                3
rd
November 2023 A002777 15ml Bottle & Carton Label (same as 07
th
July 2021)
3
rd
November 2023 A002777 25ml Bottle & Carton Label (same as 07
th
July 2021)
3
rd
November 2023 A002777 Common Leaflet (same as 07
th
July 2021)
3
rd
November 2023 A002777 Common Leaflet (same as 07
th
July 2021)
                                
                                전체 문서 읽기